Related Experiment Video
Updated: Jan 18, 2026
Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
Published on: April 21, 2022
Combining Chemotherapeutic Agents, Targeted Therapies, Vaccines and Natural Bioactive Compounds for Mesothelioma:
Raffaele Carrano1, Carlotta Zucca1, Nicla Cristina1
1Department of Clinical Sciences and Translational Medicine, University of Rome "Tor Vergata", Rome, 00133, Italy.
Abstract:
Mesothelioma is a rare and aggressive cancer with a poor prognosis and limited therapeutic options. Despite recent advances, conventional treatment approaches remain largely ineffective due to late diagnosis, chemoresistance and immunosuppressive tumor microenvironment. This review reports the latest studies on combination therapies for mesothelioma, focusing on the potential of integrating chemotherapeutic agents, molecularly targeted agents, vaccines and natural bioactive compounds such as polyphenols. Clinical and preclinical studies demonstrate that integrating immune-modulating drugs or molecular inhibitors with chemotherapy can improve survival and reduce tumor progression in mesothelioma models and patients. Vaccine-based strategies show potential for inducing host-persistent immune responses when combined with conventional treatments. Moreover, natural compounds such as polyphenols show synergistic effects with chemotherapeutics and targeted agents by modulating several signaling pathways involved in cancer cell growth and progression and by overcoming drug resistance. While several combination strategies are under clinical investigation, further studies are needed to develop more effective and personalized therapeutic approaches that could be translated into standardized treatment protocols.
Insights
Combination therapies, including chemotherapy, targeted agents, vaccines, and natural compounds like polyphenols, show promise for improving outcomes in mesothelioma treatment. Further research is needed for personalized mesothelioma treatment protocols.
Area of Science:
- Oncology
- Cancer Research
- Immunotherapy
Background:
- Mesothelioma is a rare, aggressive cancer with poor prognosis and limited treatment options.
- Conventional therapies are often ineffective due to late diagnosis, chemoresistance, and an immunosuppressive tumor microenvironment.
Purpose of the Study:
- To review the latest combination therapies for mesothelioma.
- To explore the potential of integrating various agents, including chemotherapy, targeted therapies, vaccines, and natural compounds.
Main Methods:
- Review of clinical and preclinical studies on mesothelioma combination therapies.
- Analysis of synergistic effects and immune-modulating properties of different treatment modalities.
Main Results:
- Combination therapies integrating immune-modulating drugs or molecular inhibitors with chemotherapy improve survival and reduce tumor progression.
- Vaccine-based strategies combined with conventional treatments show potential for inducing immune responses.
- Natural compounds like polyphenols exhibit synergistic effects with chemotherapeutics and targeted agents, overcoming drug resistance.
Conclusions:
- Combination strategies, including chemotherapy, targeted agents, vaccines, and natural compounds, offer promising avenues for mesothelioma treatment.
- Further research is essential to develop more effective, personalized therapeutic approaches and standardized treatment protocols for mesothelioma.
More Related Videos
07:54Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
Published on: December 21, 2019
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
Related Concept Videos
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:27Tumor Immunotherapy
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
01:30Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:17The Tumor Microenvironment